Outer membrane protein change combined with co-existing TEM-1 and SHV-1 β-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae

被引:43
作者
Wu, TL
Siu, LK
Su, LH
Lauderdale, TL
Lin, FM
Leu, HS
Lin, TY
Ho, M
机构
[1] Natl Hlth Res Inst, Div Clin Res, Taipei 11529, Taiwan
[2] Chang Gung Mem Hosp, Lin Kou Med Ctr, Dept Clin Pathol, Taipei 11529, Taiwan
关键词
D O I
10.1093/jac/47.6.755
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nine isolates of Klebsiella pneumoniae, obtained from one colonized and eight bacteraemic patients on a paediatric ward, were shown to be identical by PFGE, indicating an outbreak. Screening for extended-spectrum beta -lactamase (ESBL) production using the double-disc synergy test, Etest for ESBLs and agar diffusion tests indicated ESBL production. The isolates showed reduced susceptibility to cefotaxime but not to other third-generation cephalosporins. Molecular studies revealed production of TEM-1 and SHV-1 but no ESBLs were identified. Deficiency in expression of an outer membrane protein (OmpK35) was also observed. These observations led us to postulate that the extremely low level of OmpK35 expression and the co-existence of TEM-1 and SHV-1 resulted in an increased MIC of cefotaxime and the false designation of the isolates as ESBL producers. All the infected infants were treated with either third-generation cephalosporins alone or multiple antibiotics including a third-generation cephalosporin, and recovered and were discharged without sequelae.
引用
收藏
页码:755 / 761
页数:7
相关论文
共 31 条
[1]  
ALBERTI S, 1995, INFECT IMMUN, V63, P903
[2]   Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems [J].
Ardanuy, C ;
Liñares, J ;
Domínguez, MA ;
Hernández-Allés, S ;
Benedi, VJ ;
Martínez-Martínez, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1636-1640
[3]  
Ausubel FM, 1995, CURRENT PROTOCOLS MO
[4]   A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia [J].
Bauernfeind, A ;
Schneider, I ;
Jungwirth, R ;
Sahly, H ;
Ullmann, U .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1924-1931
[5]  
BRUNBUISSON C, 1987, LANCET, V2, P302
[6]  
Doménech-Sánchez A, 1999, J BACTERIOL, V181, P2726
[7]   SEQUENCE OF THE GENES BLAT-1B AND BLAT-2 [J].
GOUSSARD, S ;
COURVALIN, P .
GENE, 1991, 102 (01) :71-73
[8]   CROSS-RESISTANCE TO NALIDIXIC-ACID, TRIMETHOPRIM, AND CHLORAMPHENICOL ASSOCIATED WITH ALTERATIONS IN OUTER-MEMBRANE PROTEINS OF KLEBSIELLA, ENTEROBACTER, AND SERRATIA [J].
GUTMANN, L ;
WILLIAMSON, R ;
MOREAU, N ;
KITZIS, MD ;
COLLATZ, E ;
ACAR, JF ;
GOLDSTEIN, FW .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :501-507
[9]   Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J].
Jacoby, GA ;
Han, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :908-911
[10]  
JARLIER V, 1988, REV INFECT DIS, V10, P867